19 drug approvals in 2024 that had 'big clinical impact,' according to GoodRx
2024 brought some major advancements in medicine.
That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year.
These medications are "slated to make a big clinical impact for those who need them," according to GoodRx, a California-based digital health care platform.
HOW ARE PRESCRIPTION DRUGS NAMED? A DRUG DEVELOPMENT EXPERT SHARES THE PROCESS
Earlier this month, GoodRx released a list of the 19 most influential drug and vaccine approvals of 2024, some newly designed to treat certain conditions and other existing medications that were approved for additional uses.
Here is the list in order of FDA approval date.
1. Dupixent – Additional use: Eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus)
2. Amtagvi – New medication: Advanced melanoma
3. Xolair – Additional use: Food allergies
7 OF GOOGLE'S MOST-SEARCHED HEALTH QUESTIONS IN 2024 WITH EXPERT RESPONSES
4. Wegovy – Additional use: Cardiovascular risk reduction
5. Tryvio – New medication: High blood pressure
6. Nexletol – Additional use: High cholesterol
7. Winrevair – New medication: Pulmonary arterial hypertension
8. mRESVIA – New vaccine: RSV
9. Capvaxive – New vaccine: Pneumococcal disease
10. Wakix – Additional use: Pediatric narcolepsy
5 MAJOR ALZHEIMER'S DISCOVERIES SCIENTISTS MADE IN 2024
11. Ohtuvayre – New medication: COPD
12. Kisunla – New medication: Alzheimer's disease
13. Voquezna – Additional use: Heartburn from non-erosive GERD (gastroesophageal reflux disease)
14. Zunveyl – New medication: Alzheimer's disease
15. Yorvipath – New medication: Hypoparathyroidism (low levels of the parathyroid hormone)
For more Health articles, visit www.foxnews.com/health
16. Neffy – New medication: Severe allergic reactions
17. FluMist – Additional use: Self- or caregiver-administration
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
18. Cobenfy – New medication: Schizophrenia
19. Dupixent – Additional use: COPD
In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on human health."
"This was defined as either the number of lives touched or the expected degree of impact for future medication recipients," the company wrote.
"We also prioritized medications with effectiveness or safety data that represent a notable advantage over other medications recommended by clinical treatment guidelines or mainstay medical organizations."
Fox News Digital reached out to GoodRx for comment.